AMH, FSH and AFC Explained: What Your Ovarian Reserve Tests Really Tell You

If you have undergone a fertility assessment, you have probably encountered three abbreviations:

AMH, FSH and AFC.

These are among the most commonly used ovarian reserve tests, but they do not all measure the same thing—and they certainly do not provide a simple percentage chance of becoming pregnant.

A woman can have low AMH and still conceive. Another can have a reassuring AMH level but experience difficulty becoming pregnant. And two women with exactly the same AMH can respond very differently depending on their age and reproductive history.

Understanding what these tests actually tell us—and what they do not—is therefore an important part of making informed fertility decisions.

What Is Ovarian Reserve?

Ovarian reserve refers primarily to the quantity of oocytes remaining within the ovaries.

It naturally declines with age as the follicular pool becomes progressively smaller, eventually contributing to the transition through perimenopause and menopause.

However, ovarian reserve and egg quality are not the same.

A woman may have a relatively large remaining follicular pool but, because of her age, a higher proportion of chromosomally abnormal oocytes.

Another woman may have a small ovarian reserve at a younger age while the oocytes she does produce have a younger age-related biological profile.

This distinction is fundamental.

Ovarian reserve tells us mainly about quantity. Female age tells us considerably more about expected egg quality.

ASRM emphasizes that ovarian reserve markers are useful for predicting response to ovarian stimulation but are much weaker independent predictors of pregnancy and live birth.

What Does AMH Tell You?

Anti-Müllerian Hormone (AMH) is produced by granulosa cells surrounding small developing follicles.

Because the amount of AMH generally reflects the population of these follicles, it provides an indirect estimate of ovarian reserve.

AMH is particularly useful because it can generally be measured at any point during the menstrual cycle.

A lower AMH usually suggests:

• A smaller remaining follicular pool
• Potentially fewer follicles responding to IVF stimulation
• A greater likelihood of retrieving fewer oocytes

A higher AMH generally predicts a stronger quantitative response to stimulation.

But there is one very important limitation:

AMH does not directly measure egg quality.

Nor does a low AMH result mean that natural pregnancy is impossible.

Its greatest clinical value is helping fertility specialists anticipate how the ovaries may respond to stimulation and plan treatment accordingly.

What Does FSH Measure?

Follicle-Stimulating Hormone (FSH) is produced by the pituitary gland rather than the ovary.

Its job is to stimulate ovarian follicles.

As ovarian reserve declines, the ovaries may become less responsive to stimulation. The body can compensate by producing more FSH.

An elevated basal FSH can therefore indicate diminished ovarian reserve.

Unlike AMH, however, FSH can vary substantially between menstrual cycles.

For ovarian-reserve assessment, basal FSH is usually measured together with estradiol during approximately cycle days 2–4.

A single normal FSH result should therefore not automatically be interpreted as evidence of excellent ovarian reserve.

AMH can begin declining before FSH becomes elevated, which is one reason AMH has become such an important marker in modern fertility assessment.

What Is Antral Follicle Count?

Unlike AMH and FSH, Antral Follicle Count (AFC) is not a blood test.

It is measured using transvaginal ultrasound.

During the early part of the menstrual cycle, the ovaries contain a number of small follicles that can be visualized by ultrasound. The total number seen across both ovaries constitutes the AFC.

A higher AFC generally suggests that more follicles may be available to respond during ovarian stimulation.

A lower AFC suggests a smaller recruitable follicular pool.

When performed by an experienced fertility specialist, AFC provides valuable real-time information about the ovaries.

AMH and AFC are considered broadly comparable in their ability to predict ovarian response.

AMH, FSH and AFC: Why Do We Need More Than One Number?

Each marker looks at ovarian function from a slightly different perspective.

AMH reflects hormone production from small developing follicles.

FSH reflects how strongly the pituitary may need to stimulate the ovaries.

AFC allows the follicles themselves to be visualized by ultrasound.

The results do not always agree perfectly.

For example, a woman may have a low AMH but an AFC that looks somewhat more encouraging.

This does not necessarily mean one test is wrong.

Biological variation, laboratory differences, hormonal contraception, timing and ultrasound technique can all influence interpretation.

Rather than searching for one “perfect” number, the fertility specialist considers the overall ovarian picture.

Does Low AMH Mean Poor Egg Quality?

No.

This is probably the most important misconception surrounding ovarian reserve testing.

AMH primarily provides information about egg quantity, not the chromosomal quality of individual eggs.

Female age is much more strongly associated with oocyte chromosome competence.

Consider two women with the same AMH of 0.7 ng/mL.

One is 31.

The other is 42.

Their expected response to stimulation may share some similarities because both have reduced ovarian reserve.

But their reproductive prognosis is not the same because age has a major effect on the probability that an oocyte will produce a chromosomally competent embryo.

This is why an AMH result should never be interpreted without age.

Can You Get Pregnant with Very Low AMH?

Yes.

Very low AMH means that fewer follicles may be available. It does not prove that no viable oocyte remains.

ASRM specifically states that even extremely low AMH should not be used as a reason to refuse IVF treatment.

For natural conception, ovarian reserve markers are also much less predictive than many patients assume.

Pregnancy requires an ovulated egg, healthy sperm, fertilization, embryo development, a receptive uterus and successful implantation.

AMH alone cannot measure that entire process.

This is why low ovarian reserve and infertility are not synonymous.

What Do These Tests Mean After 40?

After 40, ovarian reserve testing remains useful—but age becomes even more important.

AMH and AFC can help answer:

How many follicles might respond if we stimulate the ovaries?

They cannot reliably answer:

Will those eggs produce a healthy embryo?

For women considering IVF with their own eggs after 40, fertility assessment therefore needs to combine:

age + AMH + AFC + previous ovarian response + oocyte yield + embryo development.

A previous IVF cycle can sometimes provide more useful information than repeating several ovarian reserve tests.

What Happens During Perimenopause?

As ovarian reserve approaches depletion, hormonal patterns become increasingly variable.

During perimenopause, women may experience irregular cycles, fluctuating estrogen and FSH levels, and intermittent ovulation.

AMH is generally very low by this stage, while FSH may become increasingly elevated.

However, perimenopause is not the same as postmenopause.

Ovarian activity can still occur intermittently during the menopausal transition.

For women who still wish to conceive, ultrasound evidence of follicular activity can therefore become particularly important.

Ovarian Reserve Tests and Premature Ovarian Insufficiency

Premature ovarian insufficiency (POI) involves substantial loss of ovarian function before age 40.

Women may have irregular or absent menstruation, elevated FSH and very low AMH.

However, POI does not necessarily mean permanent complete ovarian inactivity. Intermittent follicular activity can occur.

This distinction is particularly important when fertility treatment or regenerative ovarian approaches are being considered.

The question becomes not simply:

“How low is the AMH?”

but:

“Is there evidence that biologically useful ovarian activity remains?”

Can Ovarian Reserve Tests Show Whether Regenerative Treatment Is Working?

Ovarian reserve markers can form part of follow-up after regenerative ovarian treatment, but they should not be considered in isolation.

For women undergoing approaches such as ovarian PRP, enriched PRP, stem-cell-based therapy or exosome therapy, assessment may include:

• AMH
• FSH and estradiol
• AFC
• Menstrual activity
• Follicular development
• Response to subsequent ovarian stimulation
• Number of mature oocytes retrieved

A change in AMH may be interesting, but from a fertility perspective, evidence of follicular recruitment, improved ovarian response or successful oocyte retrieval can be more clinically meaningful.

At Chania Fertility Unit, this broader assessment is particularly relevant when regenerative fertility strategies are considered for women with diminished ovarian reserve, poor ovarian response, POI or perimenopausal ovarian decline.

Frequently Asked Questions

Which is more important, AMH or AFC?

Both are useful and broadly comparable for predicting ovarian response. AMH provides a blood-based biomarker, while AFC provides direct ultrasound visualization of recruitable follicles.

What is a good AMH level?

AMH must be interpreted according to age, laboratory method and clinical context. A single universal “good” AMH value cannot determine fertility.

Can I have low AMH but normal FSH?

Yes. AMH often declines before FSH rises, so diminished ovarian reserve can be present despite a normal basal FSH result.

Does high FSH mean menopause?

Not necessarily. FSH can rise with declining ovarian reserve and can fluctuate considerably, particularly during perimenopause. Menopause is not diagnosed from one FSH result alone.

Can low AMH predict menopause?

AMH declines as the follicular pool decreases, but an individual AMH measurement cannot reliably tell a woman the exact age at which she will reach menopause.

Can AMH tell me whether IVF will work?

AMH can help predict how many eggs may be obtained during stimulation, but it is much less useful for predicting whether those eggs will ultimately produce a pregnancy or live birth.

AMH, FSH and AFC: Numbers That Need Context

AMH, FSH and AFC provide valuable information—but none should be treated as a fertility verdict.

AMH and AFC help estimate the remaining follicular pool and expected ovarian response.

FSH provides additional information about how the reproductive hormonal system is responding to declining ovarian function.

Age adds another essential dimension because it is much more strongly related to egg quality.

And previous IVF response tells us how the ovaries have actually behaved under stimulation.

The most useful interpretation therefore comes from combining:

AMH + FSH + AFC + age + menstrual history + ultrasound + previous treatment response.

For women with diminished ovarian reserve, POI, perimenopausal ovarian decline or previous poor IVF response, these measurements can also help determine whether additional fertility strategies—including regenerative ovarian approaches—are worth exploring.

The goal of ovarian reserve testing should never be to reduce fertility to a laboratory number.

It should be to understand where ovarian function currently stands and use that information to make better decisions about what comes next.